 |
市場調査レポート
商品コード
1452802
持続グルコースモニタリングデバイスの世界市場規模、シェア、成長分析、コンポーネント別、最終用途別 - 産業予測2024～2031年Global Continuous Glucose Monitoring Devices Market Size, Share, Growth Analysis, By Component(Transmitters, Sensors), By End-Use(Hospitals, Home Care) - Industry Forecast 2024-2031 |
||||||
| 持続グルコースモニタリングデバイスの世界市場規模、シェア、成長分析、コンポーネント別、最終用途別 - 産業予測2024～2031年 |
|
出版日: 2024年03月09日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3～5営業日
|
- 全表示
- 概要
- 目次
世界の持続グルコースモニタリングデバイスの市場規模は、2022年に80億米ドルとなり、2023年の84億米ドルから、2031年までには124億1,000万米ドルに成長し、予測期間（2024年～2031年）のCAGRは5％で成長する見通しです。
糖尿病患者の増加と持続グルコースモニタリング（CGM）デバイスの普及が市場を押し上げています。これらのデバイスは侵襲性が低く、糖尿病の管理が容易であることで知られています。また、血糖値の大きな変化を検出し、危険な低下を防ぐことができます。センサーにより、CGM装置はさまざまな時間に血糖値をチェックします。収集されたデータはワイヤレスでソフトウェアに送られ、糖尿病患者が自分の状態をよりよく理解し、より効果的に管理するのに役立ちます。喫煙、太りすぎ、運動不足、高血圧、高コレステロール値などの一般的なことは、糖尿病を悪化させる可能性があります。国際糖尿病連合によると、2022年には約5億3,660万人が糖尿病を患っており、この数は2030年には6億4,280万人、2045年には7億8,370万人に増加すると予想されています。CGMデバイスは、食事内容、薬の服用方法、活動量、その他の健康状態に関する情報も提供します。デジタルツールは、CGMデバイスを製造する企業が糖尿病患者とつながることを容易にしました。市場には、CGM機器からのデータを使用して、将来起こるかもしれないことを確認し、ライフスタイルの変更を提案するアプリがたくさんあります。Abbott、Dexcom、Medtronicなどの企業は、COVID-19の大流行時に多くの人が必要としたため、糖尿病製品でより多くの利益を上げています。血糖値をチェックするデバイスは、糖のレベルを制御するのに役立つことが示されており、糖尿病患者が自分の状態をよりよく管理するのに役立つ可能性があります。COVID-19の大流行時には、世界中の多くの政府がこれらのデバイスにお金を出し始めたので、より多くの糖尿病患者やヘルスケアプロバイダーが使い始めました。
目次
エグゼクティブサマリー
- 市場概要
- 運命の輪
調査手法
- 情報調達
- 二次・一次情報源
- 市場規模の推定
- 市場の前提条件と制限
親市場の分析
- 市場概要
- 市場規模
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
主な市場の考察
- 技術分析
- 価格分析
- サプライチェーン分析
- バリューチェーン分析
- 市場のエコシステム
- IP分析
- 貿易分析
- スタートアップ分析
- 原材料の分析
- イノベーションマトリクス
- パイプライン製品の分析
- マクロ経済指標
- 主な投資の分析
- 主な成功要因
- 競合の程度
市場力学と見通し
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- 規制情勢
- ポーターの分析
- 将来の混乱についての特別な考察
持続グルコースモニタリングデバイスの世界市場：コンポーネント別
- 市場概要
- 送信機
- センサー
- 受信機
持続グルコースモニタリングデバイスの世界市場：最終用途別
- 市場概要
- 病院
- ホームケア
- その他
持続グルコースモニタリングデバイスの世界市場規模：地域別
- 市場概要
- 北米
- 米国
- カナダ
- 欧州
- ドイツ
- スペイン
- フランス
- 英国
- その他欧州地域
- アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋
- ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
- 中東・アフリカ（MEA）
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域
競合情勢
- 上位5社の比較
- 主要企業の市場ポジショニング（2021年）
- 主な市場企業が採用した戦略
- 主要成功戦略
- 市場における最近の活動
- 主要企業の市場シェア（2021年）
主要企業プロファイル
- Abbott（USA）
- Dexcom（USA）
- Medtronic（Ireland）
- Roche Diagnostics（Switzerland）
- Senseonics Holdings（USA）
- Lifespan（South Korea）
- Ascensia Diabetes Care（Switzerland）
- Nemaura Medical（UK）
- Ypsomed（Switzerland）
- Glysens（USA）
- Tandem Diabetes Care（USA）
- MedAngel（Belgium）
- Bigfoot Biomedical（USA）
- Novo Nordisk（Denmark）
- Sensionics（USA）
- MicroPort（China）
- Insulet Corporation（USA）
- GluSense（Israel）
- DarioHealth（USA）
- Admetsys（USA）
The Global Continuous Glucose Monitoring Devices Market size was valued at USD 8 billion in 2022 and is poised to grow from USD 8.40 billion in 2023 to USD 12.41 billion by 2031, growing at a CAGR of 5% in the forecast period (2024- 2031).
The increasing number of people with diabetes and the growing use of continuous glucose monitoring (CGM) devices are pushing the market forward. These devices are known for being less invasive and making it easier to manage diabetes. They can also detect big changes in blood sugar levels and prevent dangerous drops. With a sensor, CGM devices check blood sugar levels at different times. The data they collect is sent wirelessly to software that helps people with diabetes understand their condition better and manage it more effectively. Common things like smoking, being overweight, not being active, high blood pressure, and high cholesterol levels can make diabetes worse. According to the International Diabetes Federation, about 536.6 million people had diabetes in 2022, and this number is expected to go up to 642.8 million by 2030 and 783.7 million by 2045. CGM devices also give information about what people eat, how they take medicine, how active they are, and other health conditions. Digital tools have made it easier for companies that make CGM devices to connect with people with diabetes. There are lots of apps on the market that use data from CGM devices to see what might happen in the future and suggest changes to lifestyle. Companies like Abbott, Dexcom, and Medtronic have made a lot more money from their diabetes products because more people wanted them during the COVID-19 pandemic. Devices that check blood sugar levels have been shown to help control sugar levels and might help people with diabetes manage their condition better. Many governments around the world started paying for these devices during the COVID-19 pandemic, so more people with diabetes and healthcare providers started using them.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Continuous Glucose Monitoring Devices Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Continuous Glucose Monitoring Devices Market Segmental Analysis
Global Continuous Glucose Monitoring Devices Market is segmented on the basis of Component, End - User, Region. By Component, the market is segmented Transmitters, Sensors, Receivers. By End - user, the market is segmented into Hospitals, Home Care, Others. By Region, the market is segmented into North America, Europe, Latin America, Asia- Pacific, Middle East and Africa.
Drivers of the Global Continuous Glucose Monitoring Devices Market
The growing number of people with diabetes worldwide is a big reason why there's a need for better ways to check and manage it, like continuous glucose monitoring devices.
Restraints in the Global Continuous Glucose Monitoring Devices Market
Continuous glucose monitoring devices are now being combined with digital health platforms, which makes it easy for users to keep track of and manage their data together with other health information.
Market Trends of the Global Continuous Glucose Monitoring Devices Market
More and more, Continuous Glucose Monitoring Devices systems are using Industry 4.0 technologies like sensors, internet connection, and predictive maintenance. This helps to watch them in real-time and make them work better.
Table of Contents
Executive Summary
- Market Overview
- Wheel of Fortune
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Global Continuous Glucose Monitoring Devices Market by Component
- Market Overview
- Transmitters
- Sensors
- Receivers
Global Continuous Glucose Monitoring Devices Market by End-Use
- Market Overview
- Hospitals
- Home Care
- Others
Global Continuous Glucose Monitoring Devices Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
- By Development
- By Company
- By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
Key Company Profiles
- Abbott (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Dexcom (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Medtronic (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Roche Diagnostics (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Senseonics Holdings (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Lifespan (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Ascensia Diabetes Care (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Nemaura Medical (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Ypsomed (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Glysens (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Tandem Diabetes Care (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- MedAngel (Belgium)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bigfoot Biomedical (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Novo Nordisk (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sensionics (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- MicroPort (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Insulet Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- GluSense (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- DarioHealth (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Admetsys (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
